Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma
Clinical trial NCT05075460 · UNKNOWN
Trial details
- NCT number
- NCT05075460
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-05-30
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.